HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.

Abstract
3-halo-4,5-dihydroisoxazoles are attractive warheads for the selective inhibition of nucleophilic active sites in biological systems. A series of 3-bromo-4,5-dihydroisoxazole compounds were prepared and tested for their ability to irreversibly inhibit human transglutaminase 2 (TG2), an enzyme that plays an important role in the pathogenesis of diverse disorders including Celiac Sprue and certain types of cancers. Several compounds showed high specificity for human TG2 (k(inh)/K(I) > 2000 min(-1)M(-1)) but essentially no reactivity (k < 1 min(-1)M(-1)) toward physiological thiols such as glutathione. The pharmacokinetic and pharmacodynamic properties of a prototype dihydroisoxazole inhibitor, 1b, were evaluated; in mice the compound showed good oral bioavailability, short serum half-life and efficient TG2 inhibition in small intestinal tissue, and low toxicity. It also showed excellent synergism with N,N'-bis(2-chloroethyl)-N-nitrosourea (BCNU, carmustine) against refractory glioblastoma tumors in mice. A fluorescent dihydroisoxazole inhibitor 5 facilitated microscopic visualization of TG2 endocytosis from the extracellular surface of HCT-116 cells. Together, these findings demonstrate the promise of dihydroisoxazole compounds as probes for the biology of TG2 and its role in human disease.
AuthorsKihang Choi, Matthew Siegel, Justin L Piper, Liya Yuan, Eun Cho, Pavel Strnad, Bishr Omary, Keith M Rich, Chaitan Khosla
JournalChemistry & biology (Chem Biol) Vol. 12 Issue 4 Pg. 469-75 (Apr 2005) ISSN: 1074-5521 [Print] United States
PMID15850984 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Isoxazoles
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases
  • GTP-Binding Proteins
  • Carmustine
Topics
  • Animals
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Apoptosis (drug effects)
  • Biological Availability
  • Carmustine (pharmacology)
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Drug Synergism
  • Enzyme Inhibitors (chemistry, pharmacokinetics, pharmacology)
  • GTP-Binding Proteins (antagonists & inhibitors, biosynthesis)
  • Glioblastoma (drug therapy, pathology)
  • Intestine, Small (drug effects, metabolism)
  • Isoxazoles (chemistry, pharmacokinetics, pharmacology)
  • Mice
  • Mice, Inbred C3H
  • Microscopy, Confocal
  • Protein Glutamine gamma Glutamyltransferase 2
  • Structure-Activity Relationship
  • Transglutaminases (antagonists & inhibitors, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: